Investing.com -- HUTCHMED (NASDAQ:HCM) stock gained 1.9% in premarket trading Wednesday after the company announced that its Phase III trial of sovleplenib in patients with warm antibody autoimmune ...
Fred Hutch marked its 50th anniversary in 2025, giving the organization an opportunity to reflect on the impact we've made and to look ahead to our future. From groundbreaking science to compassionate ...
THE home where a man brutally murdered a doctor and her 14-year-old daughter has hit the market for £125,000. In October 2020 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback